MTACU
MedTech Acquisition Corporation [MTACU] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MTACU Stock Summary
In the News
MTACU Financial details
Company Rating
-
Market Cap
84.29M
Income
-46.07M
Revenue
16.02M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-0.41
Forward P/E
-
PEG
-0.08
P/S
-
P/B
-0.15
P/C
-
P/FCF
-
Quick Ratio
2.02
Current Ratio
0.03
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.66
EPS next Y
-
EPS next Q
-
EPS this Y
62.73%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
12.6%
EPS Q/Q
-81.58%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-9%
ROE
-2%
ROC
-0.65%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.23-11.43
52W High
+3.18%
52W Low
+26.11%
RSI
-
Rel Volume
21.01
Avg Volume
94
Volume
1.98K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
19.47%
-
-
-
-
Beta
-0.042253
-
-
Volatility
0.8%, 0.8%
Prev Close
0%
Price
11.35
Change
13.5%
Company Profile
- Volume Average 94
- Market Capitalization 84.29M
- CEO Mr. Christopher C. Dewey
- Headquarters Greenwich,CT,US
- IPO Date 2020-12-18
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.
